Researcher.Life Logo

Current Oncology : Impact Factor & More

eISSN: 1718-7729pISSN: 1198-0052
JournalOpen Access

Key Metrics

CiteScore
3.5
Impact Factor
< 5
Scite Index
0.86 5-Year SI
SNIP
1.14
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Oncology

Current Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 1800
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Current Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Oncology

High-Grade Glioma Tumoral Cells in a Case of Postoperative, Recurrent Subdural Hematoma… Where Did They Come From?
  • 10 May 2026
  • Current Oncology
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study
  • 5 May 2026
  • Current Oncology
The Implementation of a Caregiver Distress Screening Initiative in a Pediatric Oncology Healthcare Setting: A Quality Improvement Project
  • 28 Apr 2026
  • Current Oncology
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”
  • 27 Apr 2026
  • Current Oncology
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients
  • 26 Apr 2026
  • Current Oncology
A Case of Primary EGFR T790M Mutation in Treatment-Naïve Advanced NSCLC: Clinical and Molecular Implications
  • 24 Apr 2026
  • Current Oncology
High-Grade Glioma Tumoral Cells in a Case of Postoperative, Recurrent Subdural Hematoma… Where Did They Come From?
  • 10 May 2026
  • Current Oncology
Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study
  • 5 May 2026
  • Current Oncology
The Implementation of a Caregiver Distress Screening Initiative in a Pediatric Oncology Healthcare Setting: A Quality Improvement Project
  • 28 Apr 2026
  • Current Oncology
Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”
  • 27 Apr 2026
  • Current Oncology
Outcomes of Double-Hit and Single High-Risk Cytogenetic Newly Diagnosed Myeloma in Transplant-Eligible Patients
  • 26 Apr 2026
  • Current Oncology
A Case of Primary EGFR T790M Mutation in Treatment-Naïve Advanced NSCLC: Clinical and Molecular Implications
  • 24 Apr 2026
  • Current Oncology

FAQs on Current Oncology